Search Results

Proteomic analysis of supernatant from pooled buffy-coat platelet concentrates throughout 7-day storage.

• Authors : Glenister KM; Research Unit, Australian Red Cross Blood Service, Melbourne, Victoria, Australia.; Payne KA

Subjects: Blood Preservation*; Blood Platelets/Blood Platelets/Blood Platelets/*chemistry ; Proteins/Proteins/Proteins/*analysis

• Source: Transfusion [Transfusion] 2008 Jan; Vol. 48 (1), pp. 99-107. Date of Electronic Publication: 2007 Sep 24.Publisher: American Association Of Blood Banks Country of Publication: United States NLM ID: 0417360 Publication Model: Print-Electronic Cited Medium:

Record details

Study Results from Mayo Clinic Provide New Insights into Immunoglobulins [Outcomes of Patients With R/r B-cell Nhl and Limited (<5 Sites) Pre-cart Disease Bridged With or Without Radiotherapy].

Subjects: BLOOD proteins; ANTIGEN receptors; REPORTERS & reportingJACKSONVILLE (Fla.)

• Source: Hematology Week; 10/22/2024, p2297-2297, 1p

Record details

Early Clinical Study of Allogenic CD19-CAR-NK Cells (JD001) in the Treatment of Refractory or Relapsed(r/r) B-cell Hematologic Malignancies.

Subjects: HEMATOLOGIC malignancies; SYPHILIS; ARRHYTHMIA

• Source: Women's Health Weekly; 3/10/2023, p69-69, 1p

Record details

Reports Outline B-Cell Lymphoma Study Results from Washington University (Bridging Therapy With Axicabtagene Ciloleucel for Large B-cell Lymphoma: Results From the Us Lymphoma Car-t Consortium).

Subjects: CONSORTIA; LYMPHOMAS; LEUKAPHERESIS

• Source: Cancer Gene Therapy Week; 4/22/2024, p37-37, 1p

Record details

Data on Cell Adhesion Molecules Published by a Researcher at Chang Gung Memorial Hospital (Manufacturing of a Subsequent Autologous CAR-T Product after Prior CAR-T Is Safe and Feasible).

Subjects: CELL adhesion molecules; RESEARCH personnel; CD antigens

• Source: Genomics & Genetics Weekly; 12/22/2023, p488-488, 1p

Record details

Studies from Third Affiliated Hospital of Sun Yat-Sen University Add New Findings in the Area of Leukemia (The effects of large-volume leukapheresis on hemoglobin, platelet and coagulation in patients with hyperleukocytic leukemia).

Subjects: LEUKAPHERESIS; HEMOGLOBINS; LEUKEMIASUN Yat-Sen University (Guangdong, China)

• Source: Hematology Week; 5/8/2023, p479-479, 1p

Record details

Data on B-Cell Lymphoma Detailed by a Researcher at Vanderbilt University Medical Center (Impact of Patient Distance from Center on Outcomes and Cost of Therapy for Patients Undergoing Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma).

Subjects: IMMUNOLOGIC receptors; CANCER chemotherapy; BLOOD proteins

• Source: Cancer Gene Therapy Week; 12/23/2024, p12-12, 1p

Record details

Data from Weizmann Institute of Science Provide New Insights into Personalized Medicine (Single Cell Analysis of Pre-Treatment Peripheral Immune Composition Can Predict CAR-T Outcomes in Patients with Diffuse Large B-Cell Lymphoma).

Subjects: BONE marrow cells; DIFFUSE large B-cell lymphomas; BONE marrow cancer

• Source: Cancer Gene Therapy Week; 12/23/2024, p11-11, 1p

Record details

A Single-arm, Open-label, Single-center, Multiple-dose Early Exploratory Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of KSD-201 in Patients with Advanced Clear Cell Renal Cell Carcinoma.

Subjects: MONONUCLEAR leukocytes; BONE marrow cells; MYELOID cells

• Source: Cancer Vaccine Week; 12/19/2024, p24-24, 1p

Record details

A Phase I Trial of Intraperitoneal Mesothelin-Targeted CAR T-Cell Therapy in Patients With Mesothelin-Positive Esophagogastric Adenocarcinoma With Peritoneal Carcinomatosis.

Subjects: HEPATITIS C; AIDS; DIGESTIVE system diseases

• Source: Cancer Vaccine Week; 10/14/2024, p20-20, 1p

Record details